These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26722378)

  • 1. Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors.
    Wu SC; Chen YJ; Wang HC; Chou MY; Chang TY; Yuan SS; Chen CY; Hou MF; Hsu JT; Wang YM
    Theranostics; 2016; 6(1):118-30. PubMed ID: 26722378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging specificity of MR-optical imaging agents following the masking of surface charge by poly(ethylene glycol).
    Wu SC; Lin KL; Wang TP; Tzou SC; Singh G; Chen MH; Cheng TL; Chen CY; Liu GC; Lee TW; Hu SH; Wang YM
    Biomaterials; 2013 May; 34(16):4118-4127. PubMed ID: 23465830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles.
    Kao CH; Wang JY; Chuang KH; Chuang CH; Cheng TC; Hsieh YC; Tseng YL; Chen BM; Roffler SR; Cheng TL
    Biomaterials; 2014 Dec; 35(37):9930-9940. PubMed ID: 25212525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer.
    Cheng YA; Wu TH; Wang YM; Cheng TL; Chen IJ; Lu YC; Chuang KH; Wang CK; Chen CY; Lin RA; Chen HJ; Liao TY; Liu ES; Chen FM
    J Nanobiotechnology; 2020 Aug; 18(1):118. PubMed ID: 32854720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a mucin4-targeting SPIO contrast agent for effective detection of pancreatic tumor cells in vitro and in vivo.
    Wu SC; Chen YJ; Lin YJ; Wu TH; Wang YM
    J Med Chem; 2013 Nov; 56(22):9100-9. PubMed ID: 24147888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.
    Daldrup-Link HE; Meier R; Rudelius M; Piontek G; Piert M; Metz S; Settles M; Uherek C; Wels W; Schlegel J; Rummeny EJ
    Eur Radiol; 2005 Jan; 15(1):4-13. PubMed ID: 15616814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2/neu antibody conjugated poly(amino acid)-coated iron oxide nanoparticles for breast cancer MR imaging.
    Yang HM; Park CW; Woo MA; Kim MI; Jo YM; Park HG; Kim JD
    Biomacromolecules; 2010 Nov; 11(11):2866-72. PubMed ID: 20932000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies.
    Barrett T; Koyama Y; Hama Y; Ravizzini G; Shin IS; Jang BS; Paik CH; Urano Y; Choyke PL; Kobayashi H
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6639-48. PubMed ID: 17982120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.
    Wu J; Ma R; Cao H; Wang Z; Jing C; Sun Y; Zhang Y; Yang Z; Hoffman RM; Tang J
    Anticancer Res; 2013 Feb; 33(2):419-24. PubMed ID: 23393332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual functional AuNRs@MnMEIOs nanoclusters for magnetic resonance imaging and photothermal therapy.
    Chuang YC; Lin CJ; Lo SF; Wang JL; Tzou SC; Yuan SS; Wang YM
    Biomaterials; 2014 May; 35(16):4678-87. PubMed ID: 24613648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide.
    Xiang Z; Yang X; Xu J; Lai W; Wang Z; Hu Z; Tian J; Geng L; Fang Q
    Biomaterials; 2017 Jan; 115():53-64. PubMed ID: 27888699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using ¹¹¹In-labeled bispecific radioimmunoconjugates.
    Razumienko E; Dryden L; Scollard D; Reilly RM
    Breast Cancer Res Treat; 2013 Apr; 138(3):709-18. PubMed ID: 23525982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
    Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
    J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4-Conjugated Manganese Magnetism-Engineered Iron Oxide Nanoparticles as a Potential Magnetic Resonance Imaging Contrast Agent for Tracking Transplanted β-Cells.
    Juang JH; Shen CR; Wang JJ; Wu ST; Lin SH; Chen CY; Kao CW; Chen CL; Tsai ZT; Wang YM
    Nanomaterials (Basel); 2021 Nov; 11(11):. PubMed ID: 34835906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes.
    Chen IJ; Cheng YA; Ho KW; Lin WW; Cheng KW; Lu YC; Hsieh YC; Huang CC; Chuang CH; Chen FM; Su YC; Roffler SR; Cheng TL
    Acta Biomater; 2020 Jul; 111():386-397. PubMed ID: 32417267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents.
    Funovics MA; Kapeller B; Hoeller C; Su HS; Kunstfeld R; Puig S; Macfelda K
    Magn Reson Imaging; 2004 Jul; 22(6):843-50. PubMed ID: 15234453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
    Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
    Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.